Product Images Cialis
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 9 images provide visual information about the product associated with Cialis NDC 66336-566 by Dispensing Solutions, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
NDC 66336-0566-XX - NDC 66336 0566 XX Eli Lilly
This is information on a bulk source data for Cialis 20 mg tablets from Eli Lilly and Company, Indianapolis. The tablets are yellow, almond-shaped, and film-coated. The tablets are embossed with C 20. The lot number and sample expiry date are 00-00. The bulk source NDC is 00002-4464-30. The medicine may cause headaches or flushing. A patient information sheet is provided. The tablets are distributed by a company called RX Only Solutions, Santa Ana, CA 92704.*
Chemical Structure - cialis uspi f001 structure v1
Figure - cialis uspi f001 v2
This appears to be a graph showing the plasma concentration of tadalafil, a medication used to treat erectile dysfunction. The graph shows the concentration of tadalafil in micrograms per liter (ug/L) over time in hours, ranging from 0 to 120 hours. Three different scenarios are represented: a single 20-mg dose of tadalafil, a single 5-mg dose of tadalafil, and once-daily 5-mg tadalafil following 5 consecutive days of administration. The x-axis represents the time in hours and the y-axis represents the plasma concentration of tadalafil. It is not indicated what study or research produced these results.*
Figure - cialis uspi f002 v1
This is a table showing the difference in blood pressure (measured in mmHg) between patients who took Tadalafil versus those who took a placebo. The table includes measurements for standing and supine systolic and diastolic blood pressure at different time intervals.*
Figure - cialis uspi f003 v1
Figure - cialis uspi f004 v1
Figure 5 - cialis uspi f005 v1
This is a graph showing the change in IPSS total score during treatment over 12 weeks. There are two treatment groups, one is the placebo and the other is not readable. The graph shows a significant improvement in IPSS total score in the active treatment group compared to the placebo group, with a p-value of less than 0.01.*
Figure 6 - cialis uspi f006 v1
The text describes a chart or a graph that shows the change in IPSS Total Score over the duration of a treatment in weeks. The treatment includes two options: one with the medication CIALIS 5mg and the other with a Placebo. The chart indicates a statistically significant difference between these two options, where CIALIS 5mg showed a better outcome with a 0.2% change in the IPSS Total Score (compared to Placebo).*
Figure 7 - cialis uspi f007 v1
The text describes the change from Baseline in IPSS Total Score after 12 weeks of treatment with CIALIS 5mg versus placebo. The graph accompanying the text shows a significant improvement in IPSS Total Score with CIALIS 5mg compared to placebo (p<0.01).*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.